Statement On Withdrawal Of Johnson Johnson Brand Of Baby Talcum Powder From North American Market

The Food and Drugs Authority (FDA) says it has taken note of a recent video on social media on the ongoing discussion linking the use of Johnson's baby Talcum Powder with ovarian cancers.

According to the FDA, it wishes to assure the public that it has since 2018 increased its regulatory activities and put in appropriate measures to ensure public safety in the use of all cosmetic products containing talcum powder.

In a statement released and signed by the Chief Executive Officer (C.E.O) of FDA, Delese Darko, the statement said "Talc as a product naturally found near asbestos, has the potential to become contaminated during the mining process. Over-exposure to such contaminated talc has been linked to cases of ovarian and luring cancers"

The statement also added that all talc-containing powders including Johnson's Baby Powder registered for use in Ghana are rigorously evaluated to ensure that they are asbestos-free.

The Food and Drugs Authority says it will continue to analyze cosmetic powders that contain talc for asbestos contamination, monitor closely, review any new safety data related to the use of talc in the products, take appropriate action and inform the public accordingly.

Below is a copy of the full release:

Story by: Joshua Kwabena Smith